HIGHBRIDGE CAPITAL MANAGEMENT LLC - EFFECTOR THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V116. A total of 15 filers reported holding EFFECTOR THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$124,000
-11.4%
414,621
-0.5%
0.00%0.0%
Q1 2022$140,000
-62.1%
416,533
-0.7%
0.00%
-62.5%
Q4 2021$369,000
-28.6%
419,478
+29.8%
0.01%
-42.9%
Q3 2021$517,000–323,245–0.01%–
 Download
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MMCAP International Inc. SPC 145,941$18,8560.00%
ARISTEIA CAPITAL, L.L.C. 1,540,297$153,1060.00%
Sea Otter Advisors LLC 25,000$3,2300.00%
LITTLEJOHN & CO LLC 16,666$2,1530.00%
WHITEBOX ADVISORS LLC 298,145$38,5200.00%
Citadel Advisors 27,743$3,5840.00%
III Capital Management 41,795$4,1540.00%
Tower Research Capital LLC (TRC) 23$00.00%
Parallel Advisors, LLC 64,166$4,8120.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders